Epoprostenol treatment in children with severe pulmonary hypertension.
about
The limits of oral therapy in pulmonary arterial hypertension managementDrug treatment of pulmonary hypertension in childrenPulmonary Hypertension in Children.Pediatric pulmonary arterial hypertension.Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.Prostacyclin in the intensive care setting.Non-congenital heart disease associated pediatric pulmonary arterial hypertensionAcute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.Treatment of pediatric pulmonary hypertensionCurrent challenges in pediatric pulmonary hypertension.Current and future therapeutic options for persistent pulmonary hypertension in the newborn.Sildenafil in Infants and ChildrenHeart Transplantation in a 14-Year-Old Boy in the Presence of Severe Out-of-Proportion Pulmonary Hypertension due to Restrictive Left Heart Disease: A Case Report.Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program.Bilateral lung transplantation for pediatric idiopathic pulmonary arterial hypertension: a multi-center experience.Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The EurDiagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.
P2860
Q26773209-AFD543F2-5EB2-43BD-A060-C336780E9DE1Q26996078-5B8A4B4C-9D05-425F-AB43-A2D03140F540Q30248871-DA1C292E-D43A-4382-98B0-69BED1F63C4AQ33163446-24601C0F-B70A-4036-95DB-3E7AFC8C4C1FQ33588179-32221740-2795-46D2-B14E-24F75AD8B32CQ35050464-055CAF91-7CF8-46B8-9B39-6FD54DE0B97DQ35165691-DA1F68AD-966A-4081-B965-1261345E3769Q36718346-92F3CB12-6A26-4808-B4EE-459407D9C0C9Q36763080-2B1A5BF2-50AC-4621-BB95-BCA8CBC32CF7Q37139801-216D9C93-7AC2-4644-91B1-70CAC8374060Q37230469-BC249C34-9CF9-4F7E-8936-312C9510BC00Q37540613-8CDD5605-B08D-4F4A-B173-2326C3E2C6DBQ37763202-23151C41-36DD-4222-91B3-F19DB81351ABQ38652768-E9C059B0-3F7B-4CCE-ADCA-FADC7B63890BQ39175264-AB03CCAB-5CB8-42B4-B579-C655FB7DE68FQ43527880-66A16EBA-6F6E-4042-8A9A-B35770DAB351Q44426914-79F8AADA-5282-4C9A-8DED-A56F79C167AAQ47443854-33382B10-1FDB-4871-98AC-136E08E7E991Q55001904-742BBF10-2A09-4F65-BD40-13EFF09CD142
P2860
Epoprostenol treatment in children with severe pulmonary hypertension.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Epoprostenol treatment in children with severe pulmonary hypertension.
@ast
Epoprostenol treatment in children with severe pulmonary hypertension.
@en
type
label
Epoprostenol treatment in children with severe pulmonary hypertension.
@ast
Epoprostenol treatment in children with severe pulmonary hypertension.
@en
prefLabel
Epoprostenol treatment in children with severe pulmonary hypertension.
@ast
Epoprostenol treatment in children with severe pulmonary hypertension.
@en
P2093
P2860
P356
P1433
P1476
Epoprostenol treatment in children with severe pulmonary hypertension.
@en
P2093
Alison A Hislop
Astrid E Lammers
Sheila G Haworth
Yvette Flynn
P2860
P304
P356
10.1136/HRT.2006.096412
P407
P577
2006-10-25T00:00:00Z